SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Winkelmann RA, Okeanov A, Gulak L, Remennik L, Rahu M, Storm HH. Cancer registration techniques in the new independent states of the former Soviet Union. IARC Technical Report No. 35. Lyon: IARC, 1998.
  • 2
    NielsenJ, ed. Nordic/Baltic health statistics 1996. Copenhagen: Nordic/Baltic Medico-Statistical Committee (NOMESCO), 1998.
  • 2
    BerrinoF, CapocacciaR, EstèveJ, GattaG, HakulinenT, MicheliA, SantM, VerdecchiaA, eds. Survival of cancer patients in Europe: the EUROCARE-2 study. IARC Scientific Publications No. 151. Lyon: IARC, 1999.
  • 4
    Vercelli M, Capocaccia R, Quaglia A, Casella C, Puppo A, Coebergh JW. Relative survival in elderly European cancer patients: evidence for health care inequalities. Crit Rev Oncol Hematol 2000;35: 16179.
  • 5
    Aareleid T, Rahu M. Cancer survival in Estonia from 1978 to 1987. Cancer 1991;68: 208892.
  • 6
    Thomson H, Rahu M, Aareleid T, Gornoi K. Cancer in Estonia 1968–1992: incidence, mortality, prevalence, survival. Tallinn: Institute of Experimental and Clinical Medicine, 1996.
  • 7
    Rahu M. Estonia. In: ParkinDM, WhelanSL, FerlayJ, RaymondL, YoungJ, eds. Cancer in five continents. vol. VII. IARC Scientific Publications No. 143. Lyon: IARC, 1997. 4669.
  • 8
    Brenner H, Gefeller O. An alternative approach to monitoring cancer patient survival. Cancer 1996;78: 200410.
  • 9
    Brenner H, Gefeller O. Deriving more up-to-date estimates of long term patient survival. J Clin Epidemiol 1997;50: 2116.
  • 10
    Cutler SJ, Ederer F. Maximum utilization of the life table method in analyzing survival. J Chron Dis 1958;8: 699712.
  • 11
    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53: 45781.
  • 12
    Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 1961;6: 10121.
  • 13
    Brenner H, Gefeller O, Stegmaier C, Ziegler H. More up-to-date monitoring of long-term survival rates by cancer registries: an empirical example. Meth Inform Med 2001;40: 24852.
  • 14
    Brenner H, Hakulinen T. Up-to-date long term survival curves of patients with cancer by period analysis. J Clin Oncol 2002;20: 82632.
  • 15
    Brenner H, Söderman B, Hakulinen T. Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland. Int J Epidemiol 2002;31: 45662.
  • 16
    Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodological note No. 10, End Results Evaluation Section. Bethesda, MD: National Cancer Institute, 1959.
  • 17
    Brenner H, Gefeller O, Hakulinen T. A computer program for period analysis of survival. Eur J Cancer 2002;38: 6905.
  • 18
    Brenner H, Hakulinen T. Long-term cancer patient survival achieved by the end of the 20th century: most up-to-date estimates from the nationwide Finnish cancer registry. Br J Cancer 2001;85: 36771.
  • 19
    Dickman PW, Hakulinen T, Luostarinen T, Pukkala E, Sankila R, Söderman B, Teppo L. Survival of cancer patients in Finland 1955–1994. Acta Oncol 1999;38(suppl 12): 1103.
  • 20
    Karjalainen S, Aareleid T, Hakulinen T, Pukkala E, Rahu M, Tekkel M. Survival of female breast cancer patients in Finland and in Estonia: stage at diagnosis important determinant of the difference between countries. Soc Sci Med 1989;28: 2338.
  • 21
    Rätsep V, Tigane TL. Early detection of breast and gynaecological chronic diseases, precancerous conditions and cancer. In: 2nd Baltic Congress of Oncology and Radiology, 10–12 September 1998, Riga, Latvia. Riga: 1998. 113.
  • 22
    Hakama M. Planning and designing of screening programmes. In: SankilaR, DémaretE, HakamaM, LyngeE, SchoutenLJ, ParkinDM, eds. Evaluation and monitoring of screening programmes. Brussels-Luxembourg: European Commisssion, Europe Against Cancer Programme, 2000. 1328.
  • 23
    Sant M, Eurocare Working Group. Differences in stage and therapy for breast cancer across Europe. Int J Cancer 2001;93: 894901.
  • 24
    Aareleid T, Pukkala E, Thomson H, Hakama M. Cervical cancer incidence and mortality trends in Finland and Estonia: a screened vs. an unscreened population. Eur J Cancer 1993;29A: 7459.
  • 25
    AareleidT, MägiM, eds. Vähihaigestumus Eestis 1997/Cancer incidence in Estonia 1997. Tallinn: Eesti Vähiregister/Estonian Cancer Registry, Eesti Onkoloogiakeskus/Estonian Cancer Centre, 2000.
  • 26
    Finnish Cancer Registry—Institute for Statistical and Epidemiological Cancer Research. Cancer incidence in Finland 1996 and 1997. Cancer Society of Finland Publication No. 61. Helsinki: Cancer Society of Finland, 2000.
  • 27
    ParkinDM, WhelanSL, FerlayJ, RaymondL, YoungJ, eds. Cancer in five continents. vol. VII. IARC Scientific Publications No. 143. Lyon: IARC, 1997.
  • 28
    Timberg G, Rahu M, Gornoi K, Aareleid T, Baburin A. Bladder cancer in Estonia, 1968–1992: incidence, mortality, prevalence and survival. Scand J Urol Nephrol 1997;31: 33742.